BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 215 filers reported holding BRIDGEBIO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,706,254 | -31.0% | 67,361 | -15.8% | 0.01% | 0.0% |
| Q1 2024 | $2,472,270 | -29.4% | 79,957 | -7.9% | 0.01% | -41.7% |
| Q4 2023 | $3,502,986 | +61.6% | 86,772 | +5.6% | 0.01% | +50.0% |
| Q3 2023 | $2,167,192 | +97.4% | 82,184 | +24.8% | 0.01% | +166.7% |
| Q4 2021 | $1,098,000 | -58.1% | 65,853 | +17.8% | 0.00% | -62.5% |
| Q3 2021 | $2,621,000 | -3.6% | 55,923 | +25.3% | 0.01% | -11.1% |
| Q2 2021 | $2,720,000 | +26.6% | 44,614 | +27.9% | 0.01% | +12.5% |
| Q1 2021 | $2,149,000 | – | 34,894 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $373,797,000 | 67.28% |
| Darwin Global Management, Ltd. | 2,090,149 | $128,753,000 | 25.21% |
| Affinity Asset Advisors, LLC | 577,500 | $35,574,000 | 12.08% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1,913,356,000 | 9.64% |
| Perceptive Advisors | 7,756,928 | $477,827,000 | 6.04% |
| Opaleye Management Inc. | 583,767 | $35,960,000 | 5.28% |
| MIZUHO MARKETS AMERICAS LLC | 171,923 | $10,590,000 | 4.93% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $1,639,853,000 | 4.88% |
| Fernwood Investment Management, LLC | 151,085 | $9,307,000 | 3.42% |
| HHLR ADVISORS, LTD. | 5,362,014 | $330,300,000 | 3.26% |